systemic lupus erythematosus pure membranous nephropathy research hub

Obinutuzumab for systemic lupus erythematosus pure membranous nephropathy: a phase II trial (OBLUMEN)

This clinical trial looks at whether a medicine called obinutuzumab can help adults with lupus that affects their kidneys. Researchers want to see if this treatment can reduce kidney swelling, improve kidney health over one year, and allow people to cut down on their daily steroid tablets.